CLINICAL_TRIALS
trial_result
· 2020-02-05
Clinical Trial Update: Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia [Phase 2, Phase 3]
Summary
Phase 2/3 trial assessing mirtazapine for cancer-associated anorexia-cachexia in advanced cancer patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catherine Naseef Hunter | Conditions: Advanced Cancer, Cancer Associated Anorexia - Cachexia | Phase 2, Phase 3 | Status: COMPLETED